כאן תמצאו את ג׳וב החלומות שלכם

The opportunity
As the Director, Pipeline Immunology Asset Lead – ImmunoOncology, GHEVO, you’ll serve as a principal strategic and technical GHEVO lead for immunology compounds in development. Collaborating closely with cross-functional teams, you will guide health economics, value, and outcomes research to support the value proposition of our immunology assets, shaping global strategies that impact patient lives.
How you’ll spend your day
Developing GHEVO Strategies: Lead the creation and implementation of evidence generation plans to support the value proposition of pipeline immunology assets, ensuring alignment with regulatory and governance standards. Provide insights into the development of access/HTA strategy from a GHEVO perspective and support colleagues in the implementation of this strategy
Driving Cross-functional Collaboration: Partner with clinical, medical, market access, and brand teams to for e.g. optimize trial design, incorporating health economic and patient-reported outcomes to enhance product value. Working in a cross-functional matrix team environment and effectively communicate relevant GHEVO strategies and evidence studies outputs 
Leading Global Value Team (GVT): Serve as a key leader in global strategic discussions, leading the Global Value Team for the asset to ensure its successful development and commercialization.
Conducting Innovative Health Economics and Outcomes Research: Develop cost-effectiveness and budget impact models, plan for early HTA assessments or value framework reports, or other HEOR relevant deliverables to appropriately prepare for or optimally support asset launches. Design and conduct real-world evidence studies and undertake targeted or systematic literature reviews to ensure timely quantitative understanding of economic, humanistic and clinical burden of disease, and to provide input to go/no-go decisions at each development milestone. Design and implement state of the art early-stage indirect treatment comparisons.
Engaging with Key Stakeholders: Represent Teva externally, interacting with health authorities, payers, and scientific communities to communicate the value of Teva’s immunology portfolio.
Managing HEOR Publications and Scientific Communications: Collaborate on scientific platforms to ensure accurate dissemination of HEOR findings, enhancing the evidence base for product positioning and reimbursement.
Overseeing Project Timelines and Budgets: Ensure all initiatives remain within budget and meet timelines, prioritizing activities to support strategic milestones and market access goals.